Primary Hepatocellular Carcinoma After Chronic Non-A, Non-B Post-Transfusion Hepatitis
Authors: JOHN H. GILLIAM
Journal: Annals of Internal Medicine (1984)

Brief Reports1 December 1984Primary Hepatocellular Carcinoma After Chronic Non-A, Non-B Post-Transfusion HepatitisJOHN H. GILLIAM III, M.D., KIM R. GEISINGER, M.D., JOEL E. RICHTER, M.D.JOHN H. GILLIAM III, M.D.Search for more papers by this author, KIM R. GEISINGER, M.D.Search for more papers by this author, JOEL E. RICHTER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-101-6-794 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptEpidemiologic evidence of an association between hepatitis B virus and hepatocellular carcinoma is strong, but evidence of a similar association between non-A, non-B hepatitis virus infection and hepatocellular carcinoma is less clear. Reports from Japan (1-3) and Nigeria (4) suggest that hepatitis B serum markers are negative in 5% to 28% of patients with hepatocellular carcinoma. We describe the case of a patient with well-documented chronic non-A, non-B hepatitis acquired after a transfusion who developed hepatocellular carcinoma 9 years later.A 63-year-old white man was hospitalized in November 1983 with weakness, anorexia, and weight loss of 3 weeks' duration. He...References1. OKUDAOBATAMOTOIKE HHY. Hepatocellular carcinoma (HCC) presumably associated with non-B hepatitis virus infection: clinical and pathological observations [Abstract]. Hepatology. 1982;2:113. Google Scholar2. IWAMAOHNISHINAKAJIMA SKY. A clinical study of hepatocellular carcinoma (HCC) in relation to hepatitis B seromarkers: implications of non-A, non-B hepatitis (NANB) [Abstract]. Hepatology. 1982;2:117. Google Scholar3. KENICHIHIDEOAKIRA KHI. The correlation of non-A, non-B hepatitis virus with hepatocellular carcinoma [Abstract]. Hepatology. 1982;2:157. Google Scholar4. AYOOLAODELOLAJOHNSON EHA. Primary liver cancer (PLC) after non-A, non-B hepatitis (NANBH) [Abstract]. Hepatology. 1982;2:154. Google Scholar5. DIENSTAG J. Non-A, non-B hepatitis: I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983;85:439-62. CrossrefMedlineGoogle Scholar6. SHAFRITZSHOUVALSHERMANHADZIYANNISKEW DDHSM. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma: studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med. 1981;305:1067-73. CrossrefMedlineGoogle Scholar7. HEYWARDBENDERLANIERFRANCISMCMAHONMAYNARD WTADBJ. Serologic markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos. Lancet. 1982;2:889-91. CrossrefMedlineGoogle Scholar8. SUMMERS J. Three recently described animal virus models for human hepatitis B virus. Hepatology. 1981;1:179-83. CrossrefMedlineGoogle Scholar9. ROGLERSUMMERS CJ. Cloning and characterization of integrated woodchuck hepatitis virus sequences from chronically infected liver tissue [Abstract]. Hepatology. 1983;3:875. Google Scholar10. RESNICKSTONEANTONIOLI RKD. Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. Dig Dis Sci. 1983;28:908-11. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Bowman Gray School of Medicine Wake Forest University Winston-Salem, North Carolina PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByNanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccinesPathology of liver disease: advances in the last 50 yearsHuman Microbiome and Malignancy: Principles, Mechanisms, and ChallengesHistorical review of the causes of cancerIdentifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991-2010): an age-period-cohort analysisHepatitis C VirusAn Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee ModelThe history of the “natural history” of hepatitis C (1968-2009)Antihepatitis C virus status in hepatocellular carcinoma and the influence on clinicopathological findings and operative resultsPredictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis CChoo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359–362]Malignant liver tumoursHepatitis C virus in the etiology of hepatocellular carcinomaHepatitis C : A Brief Clinical OverviewHepatocellular carcinoma in patients with HCVHepatitis C virus and hepatocellular carcinomaDilemma of the natural history of hepatitis CUse of Interferon-α for Prevention of Hepatocellular Carcinoma in Patients with Chronic Active Hepatitis C with CirrhosisOutcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplantThe Role of Hepatitis C Virus in Hepatocellular CarcinomaFine-needle aspiration cytomorphology of clear-cell hepatocellular carcinomaHepatitis C virus and hepatocellular carcinomaPatterns of progressionEVALUATION AND TREATMENT OF CHRONIC HEPATITIS C INFECTIONAlpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisAllogeneic transfusion risks in the surgical patientRandomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisLong interval between HCV infection and development of hepatocellular carcinomaA retrospective study of hepatitis C virus carriers in a local endemic town in JapanHepatitis B and C viruses in the development of hepatocellular carcinomaEffects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose studyVIRAL HEPATITIS AND HEPATOCELLULAR CARCINOMAA nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in TaiwanHepatitis C virus and hepatocellualr carcinomaChronic hepatitis CNeutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant virusesPrimary liver cancer incidence-rates related to hepatitis-C virus infection: a correlational study in Osaka, JapanDetection of hepatitis B and C viruses in liver tissue with hepatocellular carcinomaNew trends in hepatocellular carcinomaCurrent pathogenetic and molecular concepts in viral liver carcinogenesisLow serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-fu and interferon-alpha-2bProspective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitisA multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosisLong-Term Mortality after Transfusion-Associated Non-A, Non-B HepatitisThe role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part IHepatitis B and C viral infections in patients with hepatocellular carcinomaPrevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in IndiaHepatocellular carcinoma: Recent progressPosttransfusion Hepatitis in JapanHepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with Cirrhosis A Case-Control StudyRosa Giovanna Simonetti, MD, Calogero Cammà, MD, Felice Fiorello, MD, Mario Cottone, MD, Maria Rapicetta, BS, Liliana Marino, BS, Germana Fiorentino, BS, Antonio Craxì, MD, Annarita Ciccaglione, BS, Roberto Giuseppetti, BS, Tommaso Stroffolini, MD, Luigi Pagliaro, MDThe prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinomaViral Hepatitis CClinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in JapanAnti-HCV Antibodies and Hepatocellular CarcinomaLong-term clinical and histopathological follow-up of chronic posttransfusion hepatitisLow prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in TaiwanPublic health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis CPrevalence of Antibodies to Hepatitis C Virus in Saudi Patients with Chronic Liver DiseaseFrequency and Significance of Antibody to Hepatitis C Virus in Severe Corticosteroid-Treated Autoimmune Chronic Active HepatitisHepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosisHepatitis C-virus (HCV) antibodies in patients after kidney transplantationHepatocellular carcinoma following chronic delta virus hepatitis in a patient cured of leukemiaCurrent Risks of Blood TransfusionMolecular Biology of Non-A, Non-B Hepatitis Agents: Hepatitis C and Hepatitis E VirusesGamma Globulin Prophylaxis to Reduce Post-Transfusion Non-A, Non-B Hepatitis After Cardiac Surgery with Cardiopulmonary BypassTransition of Antibody to Hepatitis C Virus from Chronic Hepatitis to Hepatocellular CarcinomaInterrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virusRisk factors for hepatocellular carcinoma in catalonia, spainHepatitis C–associated hepatocellular carcinomaHepatitis D virus infection among intravenous drug abusers in Taiwan: Analysis of risk factors and liver function testsHepadnaviruses in cirrhotic liver and hepatocellular carcinomaSerum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinomaA randomized, double-blind, placebo-controlled trial of recombinant human α-interferon therapy for chronic non-A, non-B (type C) hepatitisThe hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitisPREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSISPREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMAConditions Associated with Hepatocellular CarcinomaHepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infectionChronic Consequences of Non-A, Non-B HepatitisHepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitisElevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusionsBlood Transfusion, Alcohol Consumption, and Cigarette Smoking in Causation of Hepatocellular Carcinoma: A Case-Control Study in Fukuoka, JapanNon‐A, Non‐B Hepatitis‐Related Hepatocellular Carcinoma in a ChimpanzeeRisk factors for hepatocellular carcinoma in italy. Male sex, hepatitis b virus, non-a non-B infection, and alcoholRationale for Surrogate Testing to Detect Non-A, Non-B HepatitisLiver Cancer and VirusesPost-transfusion HepatitisPrimary hepatocellular carcinoma following nonspecific non-B hepatitis with tumor DNA negative for HBV DNACirrhosis and the aetiology of hepatocellular carcinomaChronic Non-A, Non-B Hepatitis: A Long-Term Follow-up Study in 49 PatientsHepatitis in clinical practiceSouthwestern Internal Medicine Conference: The Current Status of Non-A, Non-B Viral Hepatitis 1 December 1984Volume 101, Issue 6Page: 794-795KeywordsBiopsyHepatitis AHepatitis BHepatitis B virusHepatitis virusesHepatocellular carcinomaLiverPolymerasesSurgeryWeight loss Issue Published: 1 December 1984 PDF DownloadLoading ...